Client News
Filter by:
- Mar 6 2024 Canoo Inc. Announces 1-for-23 Reverse Stock Split Effective March 8, 2024
- Mar 5 2024 Prothena to Participate in Upcoming Healthcare Conferences
- Mar 5 2024 Paratek Pharmaceuticals Announces Positive Efficacy Data for NUZYRA® as Post-Exposure Prophylaxis of Inhalational Anthrax, Triggering Additional Procurement under BARDA Project BioShield Contract
- Mar 4 2024 Prothena Appoints David Ford to Newly Created Chief People Officer Position
- Mar 4 2024 Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
- Mar 4 2024 Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort
- Mar 1 2024 ASHFORD ANNOUNCES ACCEPTANCE OF COMPLIANCE PLAN BY NYSE AMERICAN
- Feb 29 2024 Kineta Announces Restructuring and Exploration of Strategic Alternatives
- Feb 29 2024 ASHFORD HOSPITALITY TRUST ANNOUNCES PROGRESS IN PLAN TO PAY OFF STRATEGIC FINANCING WITH AGREEMENT TO SELL THE HILTON BOSTON BACK BAY
- Feb 28 2024 Cemtrex Issues Shareholder Letter and Provides Corporate Update